Jyong Biotech

MENSNasdaq Taiwan Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$180.946 M

$2.38 +10.70%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

-$4.67M

Loss-making

Shares outstanding

76,027,667

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#275Minerva NeurosciencesNERV$181.9M
#276Tonix PharmaceuticalsTNXP$181.6M
#277Jyong BiotechMENS$180.9M
#278Lifecore Biomedical, Inc. DeLFCR$170.1M
#279Kazia TherapeuticsKZIA$169.8M

What if Jyong Biotech were worth as much as…

Open the what-if tool →

Gold $30.2T

$397,670.62

Per share 167,088× higher

Bitcoin $1.74T

$22,908.17

Per share 9,625× higher

Nvidia $5.52T

$72,549.47

Per share 30,483× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Jyong Biotech are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.